Plimoth Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11M | Buy |
9,201
+322
| +4% | +$329K | 2.2% | 10 |
|
|
2026
Q1 | $8.17M | Buy |
8,879
+422
| +5% | +$428K | 1.83% | 10 |
|
|
2025
Q4 | $9.09M | Sell |
8,457
-44
| -0.5% | -$42.1K | 2.03% | 7 |
|
|
2025
Q3 | $6.49M | Buy |
8,501
+321
| +4% | +$239K | 1.47% | 11 |
|
|
2025
Q2 | $6.38M | Buy |
8,180
+367
| +5% | +$285K | 1.53% | 12 |
|
|
2025
Q1 | $6.45M | Buy |
7,813
+2,542
| +48% | +$2.12M | 1.68% | 11 |
|
|
2024
Q4 | $4.07M | Buy |
5,271
+44
| +0.8% | +$36.4K | 1.05% | 27 |
|
|
2024
Q3 | $4.63M | Sell |
5,227
-1,113
| -18% | -$1M | 1.17% | 24 |
|
|
2024
Q2 | $5.74M | Sell |
6,340
-228
| -3% | -$182K | 1.53% | 14 |
|
|
2024
Q1 | $5.11M | Sell |
6,568
-484
| -7% | -$344K | 1.36% | 20 |
|
|
2023
Q4 | $4.11M | Sell |
7,052
-210
| -3% | -$123K | 1.19% | 24 |
|
|
2023
Q3 | $3.9M | Sell |
7,262
-502
| -6% | -$259K | 1.22% | 23 |
|
|
2023
Q2 | $3.64M | Sell |
7,764
-135
| -2% | -$56.6K | 1.09% | 26 |
|
|
2023
Q1 | $2.71M | Sell |
7,899
-233
| -3% | -$78.6K | 0.84% | 42 |
|
|
2022
Q4 | $2.98M | Sell |
8,132
-1,079
| -12% | -$383K | 0.96% | 34 |
|
|
2022
Q3 | $2.98M | Buy |
9,211
+26
| +0.3% | +$8.24K | 1.03% | 30 |
|
|
2022
Q2 | $2.98M | Sell |
9,185
-943
| -9% | -$283K | 0.94% | 35 |
|
|
2022
Q1 | $2.9M | Sell |
10,128
-368
| -4% | -$94.7K | 0.77% | 44 |
|
|
2021
Q4 | $2.9M | Sell |
10,496
-230
| -2% | -$58.3K | 0.74% | 46 |
|
|
2021
Q3 | $2.48M | Sell |
10,726
-545
| -5% | -$135K | 0.7% | 51 |
|
|
2021
Q2 | $2.59M | Sell |
11,271
-263
| -2% | -$52.8K | 0.73% | 49 |
|
|
2021
Q1 | $2.15M | Sell |
11,534
-145
| -1% | -$28.4K | 0.64% | 51 |
|
|
2020
Q4 | $1.97M | Sell |
11,679
-2,520
| -18% | -$376K | 0.62% | 54 |
|
|
2020
Q3 | $2.1M | Buy |
14,199
+438
| +3% | +$67.8K | 0.7% | 48 |
|
|
2020
Q2 | $2.26M | Sell |
13,761
-930
| -6% | -$143K | 0.8% | 41 |
|
|
2020
Q1 | $2.04M | Sell |
14,691
-310
| -2% | -$42.6K | 0.85% | 36 |
|
|
2019
Q4 | $1.97M | Sell |
15,001
-150
| -1% | -$17.4K | 0.64% | 52 |
|
|
2019
Q3 | $1.69M | Sell |
15,151
-965
| -6% | -$107K | 0.56% | 59 |
|
|
2019
Q2 | $1.79M | Sell |
16,116
-195
| -1% | -$23K | 0.59% | 56 |
|
|
2019
Q1 | $2.12M | Sell |
16,311
-1,596
| -9% | -$194K | 0.7% | 42 |
|
|
2018
Q4 | $2.07M | Sell |
17,907
-1,095
| -6% | -$122K | 0.76% | 40 |
|
|
2018
Q3 | $2.04M | Sell |
19,002
-250
| -1% | -$25K | 0.66% | 53 |
|
|
2018
Q2 | $1.64M | Buy |
19,252
+95
| +0.5% | +$7.8K | 0.56% | 57 |
|
|
2018
Q1 | $1.48M | Buy |
19,157
+635
| +3% | +$51.1K | 0.51% | 64 |
|
|
2017
Q4 | $1.56M | Buy |
+18,522
| New | +$1.58M | 0.56% | 60 |
|
Other funds holding LLY
Plimoth Trust's LLY Position: Q2 2026 in Review
Plimoth Trust increased its Eli Lilly (LLY) stake by 3.6% in Q2 2026, buying an estimated $329K and bringing the position to 9,201 shares worth $11M. The position accounts for 2.2% of the portfolio, ranked #10.
Plimoth Trust first reported a position in LLY in Q4 2017 and has held it in 35 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Plimoth Trust held 9,201 shares of Eli Lilly worth $11M as of Q2 2026.
- Plimoth Trust bought 322 Eli Lilly shares in Q2 2026, an estimated $329K.
- Eli Lilly made up 2.2% of Plimoth Trust's portfolio in Q2 2026, its #10 holding.
- Plimoth Trust first reported a position in Eli Lilly in Q4 2017 and has held it in 35 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Plimoth Trust's 13F filing for Q2 2026, filed 28 Jul 2026.